Comparative Pharmacokinetics Study of 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil Substance and its Solid Dispersion Systems on Rabbits

par V. M. Kosman, D. V. Demchenko, E. A. Jain (Korsakova), V. G. Makarov, V. Yu. Balabanyan
Publié 2021-05-01

Development and Biopharmaceutical Evaluation of Tablets Based on the Poorly Water-soluble Substance 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil

par D. V. Demchenko, E. A. Jain (Korsakova), V. Yu. Balabanyan, M. N. Makarova, V. G. Makarov
Publié 2020-11-01

Optimization of Methods for Determination of the Encapsulation Efficiency of Doxorubicin in the Nanoparticles Based on Poly(lactic-co-glycolic acid) (PLGA)

par T. S. Kovshova, N. S. Osipova, A. S. Fortuna, Yu. V. Ermolenko, O. O. Maksimenko, V. Yu. Balabanyan, S. E. Gelperina
Publié 2020-05-01

CHARACTERISATION AND STUDY OF 1- [2- (2-BENZOYLPHENOXY) ETHYL] -6-METHYLURACIL MECHANISM OF ACTION

par E. A. Jain (Korsakova), D. V. Demchenko, A. A. Ozerov, M. N. Makarova, V. G. Makarov, V. Yu. Balabanyan
Publié 2021-07-01

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

par M. B. Sokol, N. G. Yabbarov, M. R. Mollaeva, M. V. Chirkina (Fomicheva), V. Yu. Balaban'yan, E. D. Nikolskaya
Publié 2021-11-01

EXPERIMENTAL STUDY OF TOXIC PROPERTIES OF VMU-2012-05 DRUG – ORIGINAL NON-NUCLEESIDE INHIBITOR OF HIV-1 REVERSE TRANSCRIPTASE

par V. A. Vavilova, E. V. Shekunova, E. A. Jain (Korsakova), V. Yu. Balabanyan, A. A. Ozerov, M. N. Makarova, V. G. Makarov
Publié 2021-08-01

SCIENTIFIC SCHOOL OF ACADEMICIAN VITALY I. SHVETS: BIONANOPHARMACEUTICAL TECHNOLOGIES OF INNOVATIVE DIRECTED-ACTION MEDICINAL PREPARATIONS AND MANPOWER TRAINING

par V. I. Shvets, G. M. Sorokoumova, A. I. Lyutik, A. B. Pshenichnikova, D. I. Prokhorov, N. V. Rukosueva, A. G. Yakovenko, A. M. Khort, S. N. Chvalun, Yu. M. Krasnopolsky, V. Yu. Balabanyan, E. S. Severin, A. A. Kubatiev
Publié 2017-12-01